* Guardant Health Inc GH.OQ reported a quarterly adjusted
loss
of 88 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -73 cents. The mean expectation of twenty three analysts
for the quarter was for a loss of 74 cents per share. Wall
Street expected results to range from -89 cents to -50 cents per
share.
* Revenue rose 33.9% to $191.48 million from a year ago;
analysts
expected $170.63 million.
* Guardant Health Inc's reported EPS for the quarter was a
loss
of 88 cents.
* The company reported a quarterly loss of $107.75 million.
* Guardant Health Inc shares had risen by 2.5% this
quarter and
lost 13.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 21 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Guardant Health
Inc is 42.00
This summary was machine generated from LSEG data November 7 at
04:13 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 -0.74 -0.88 Missed
Jun. 30 2024 -0.74 -0.84 Missed
Mar. 31 2024 -0.85 -0.94 Missed
Dec. 31 2023 -0.86 -0.85 Beat